- Val-Cit-PAB-MMAE
-
- $0.00 / 100mg
-
2024-03-29
- CAS:644981-35-1
- Min. Order: 100mg
- Purity: >98.00%
- Supply Ability: 100mg
|
| | Val-Cit-PAB-MMAE Basic information |
| Product Name: | Val-Cit-PAB-MMAE | | Synonyms: | Val-Cit-PAB-MMAE;4H-1-Benzopyran-4-one,7-hydroxy-4-(trifluoromethyl)-;Drug-Linker Conjugates for ADC,inhibit,Inhibitor,Val Cit PAB MMAE,ValCitPABMMAE;4-((S)-2-((S)-2-Amino-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate | | CAS: | 644981-35-1 | | MF: | C58H94N10O12 | | MW: | 1123.42676 | | EINECS: | | | Product Categories: | ADCs;ADC LINKER | | Mol File: | 644981-35-1.mol |  |
| | Val-Cit-PAB-MMAE Chemical Properties |
| solubility | Soluble in DCM | | InChIKey | WZEAGSMYTVSXQA-DQTLHWFHNA-N |
| | Val-Cit-PAB-MMAE Usage And Synthesis |
| Description | Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a a protease-sensitive Val-Cit dipeptide, and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. |
| | Val-Cit-PAB-MMAE Preparation Products And Raw materials |
|